Heartburn Medications were tested to treat Covid-19

Drugs for reducing stomach reflux or famotidine heartburn
are being tested for treatment of Covid-19 patients at New York hospitals.
The information was confirmed by officials in New York on
April 27. The trial was conducted by Feinstein Medical Research Institute
of Northwell Health, which operates a network of 23 hospitals in New York
City.
At least 187 patients participated in the
trial. Results are expected in the next few weeks. Dr Kevin Tracey,
president of the Feinstein Institute for Medical Research, said he hoped to
recruit an additional 1,200 participants.
"People are hoping for everything they can against nCoV. So this clinical trial is needed. There are many examples in medical history, showing that a drug is made for this purpose. works with another disease, "says Tracey.
Dr. Kevin also emphasized that he did not know if famotidine
would work for Covid-19 patients, but once the progress is made, the widespread
application will be very easy. However, he warned patients not to go to
the pharmacy and arbitrarily buy heartburn pills to drink.
"Patients who participated in the trial were given
intravenous heartburn medication. The doses for these patients were nine times
higher than those for ordinary heartburn," said Tracey.
Half of the patients on the trial will receive famotidine,
the other half will receive a placebo. In addition, patients are also
receiving anti-malarial drugs hydroxychloroquine.
However, hydroxychloroquine may not be recommended in the
future. Last week, the US Food and Drug Administration issued a warning
warning that the drug could pose serious cardiovascular risks when tested for
Covid-19 patients.
Dr. Tracey shared that he had an idea to study famotidine
after talking with an infectious disease specialist at Massachusetts General
Hospital. This colleague once worked with nCoV-infected patients in
China. He observed that the poor heartburn survived longer than the rich
heartburn. He found that poorer people were taking famotidine while
wealthy patients tended to take a more expensive drug.
In addition, Florida-based Alool Laboratories used a
computer model to make a list of current drugs that can combat nCoV and
famotidine that appear at the top of the list.
Tracey said that because theoretically, the structure of
famotidine helps it prevent viruses from replicating, similar to the way
protease inhibitors are used to treat HIV, against viruses. He said he
would set up an independent council to monitor the trial and make decisions
about whether to continue using the drug.
As of April 28, the world recorded more than three million
nCoV infections, of which more than 210,000 people have died, with some
countries limiting when the situation is more stable.
The largest epidemic
zone in the US recorded nearly 1 million cases, of which nearly 56,000
died. So far, the US has done nearly 5.6 million tests, the highest in the
world, but experts say this number is not enough.
Southeast Asia recorded 40,766 cases of nCoV, of which 1,445
died. Cambodia, East Timor and Laos have not recorded deaths.
No comments